DOH tasked to set guidelines on use of rapid test kits

The Inter-Agency Task Force for the Management of Emerging Infectious Diseases directed the Department of Health (DOH) on Sunday, April 12, to set guidelines for the use of rapid test kits in the Philippines.

These guidelines must comply with the requirements and recommendations of the Health Technology Assessment Council under Republic Act No. 11223 or the Universal Health Care Act.

The Food and Drug Administration (FDA) had previously approved five rapid test kits, which require blood samples to measure antibodies rather than viral load.

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

Topics in this story

Explore more stories about these topics